Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
<b>Background/Objectives:</b> Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with cardiometabolic risk. Although studies have shown that estradiol positively contributes to energy metabolism via estrogen receptor alpha (ERα), its role specifically in the l...
Saved in:
| Main Authors: | Ester S. Alves, Jessica D. M. Santos, Alessandra G. Cruz, Felipe N. Camargo, Carlos H. Z. Talarico, Anne R. M. Santos, Carlos A. A. Silva, Henrique J. N. Morgan, Sandro L. Matos, Layanne C. C. Araujo, João Paulo Camporez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pathophysiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1873-149X/32/1/1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis
by: Christian Sommerauer, et al.
Published: (2024-03-01) -
Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses
by: Miranda Dosi, et al.
Published: (2025-07-01) -
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD
by: Tianyuan Yang, et al.
Published: (2025-04-01) -
Carbohydrate intake and activation of gastric acid secretion decrease gastric estrogen secretion
by: Takao Ito, et al.
Published: (2025-03-01) -
Capsaicin (But Not Other Vanillins) Enhances Estrogen Binding to Its Receptor: Implications for Power Sports and Cancers
by: Maja Pietrowicz, et al.
Published: (2025-01-01)